The EU Court of Justice clarifies for the first time when patent settlement agreements that restrict a generic pharmaceutical company's ability to enter the market infringe the EU antitrust rules (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma)

Catriona Hatton,Paul Lugard,Daniel Vasbeck

The EU Court of Justice clarifies for the first time when patent settlement agreements that restrict a generic pharmaceutical company's ability to enter the market infringe the EU antitrust rules (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma)

2020

Catriona Hatton
Paul Lugard
Daniel Vasbeck

In a major judgment handed down on 30 January 2020 in Generics (UK) and Others, the EU Court of Justice (the Court) – the EU's highest court – clarified for the first time the analytical framework…

Keywords:

Law
European union
restrict
Political science
settlement
Economic Justice
economic analysis
Judicial review
Barriers to entry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations